Viemed Healthcare (NASDAQ:VMD) outlined its growth strategy, product diversification and capital allocation priorities at the Midwest IDEAS Conference, emphasizing its focus on providing in-home care for patients with complex respiratory conditions.
Chief Executive Officer Casey Hoyt said complex r
Viemed Healthcare (NASDAQ:VMD) reported record second-quarter revenue as growth in its ventilator business resumed under the updated Medicare coverage framework and newer service lines expanded.
Revenue for the quarter reached $78.1 million, up approximately 24% from a year earlier and 4% sequentia
Outpatient surgery giant or home-based respiratory care leader, which business model stands out as healthcare spending patterns evolve and margins diverge?
Viemed Healthcare (VMD) exemplifies a high-growth momentum stock, matching strong technical uptrend signals with accelerating fundamental earnings and sales growth.
Gainers Enanta Pharma (NASDAQ: ENTA) stock rose 15.6% to $9.13 during Friday's after-market session. The market value of their outstanding shares is at $165.6 million.
